Ex-US Clinical Trials

Randomized case-control phase II clinical studies
The goal: to test the ability of Elenagen to enhance standards of care for
  • Triple negative breast cancer
  • Ovarian cancer
  • Inoperable stomach cancer
  • Pancreatic cancer
Observation by the leading US medical centers
Pending future international clinical trials in
  • Glioblastoma
  • Metastatic hormone-resistant prostate cancer
  • Metastatic renal cancer
  • Metastatic uterus cancer
  • Melanoma

For any inquiries, please contact: info@curelab.com